WASHINGTON, Sept. 08, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced the appointment of Ralph L. Hunter, Jr. to the board of directors of ASP Isotopes and the board of managers of Quantum Leap Energy LLC. Ralph L. Hunter, Jr. has over thirty years' experience in the nuclear power industry in leadershi ...

核心观点 - 公司2025年前八个月业绩表现强劲 创下历史最佳季度业绩 并推进战略领导层重组、平台化AI创新和全球扩张计划 [1] 领导层重组与战略聚焦 - 2025年2月进行战略领导层调整 强化对北美核心客户、AI驱动企业转型和精细化运营执行的专注 [2][3] - 任命Ajay Khare为首席执行官 Daniel Webb为首席财务官 [7] - 2025年6月任命Eli Mendoza为首席增长与战略官 负责深化私募股权合作并扩展市场策略 [7] 业务进展与业绩表现 - 为美国顶级医疗金融科技平台成功完成300人以上的印度全球能力中心（GCC）过渡 [7] - 与Cority签署意向书 在印度和墨西哥推出AI驱动的GCC 展示其建设-运营-移交（BOT）模式 [7] - 2025年7月恢复纳斯达克合规 符合最低投标价格要求 [7] - 截至2025年6月30日的季度创公司历史最佳业绩 实现正经营现金流 净利润同比改善1700万美元 [7] AI平台创新与生态建设 - 推出AI合作伙伴网络 加速中型企业的AI应用落地 [7] - 发布集成生成式AI平台AeriesOne 帮助企业从试点项目扩展到生产成果 [7] 全球扩张与产能提升 - 计划在印度和墨西哥新增500个以上AI、技术、金融和运营岗位 [8] - 在孟买、班加罗尔、海得拉巴和浦那设立新办公室 [8] - 持续扩大墨西哥瓜达拉哈拉的近岸运营规模 [8] 行业定位与企业资质 - 公司专注于为私募股权投资组合企业提供AI驱动的价值创造、业务转型和GCC服务 [9] - 成立于2012年 连续两年获得"卓越职场"认证 [9]

The leading European asset manager specializing in digital assets with ~US$10 billion in AuM sets sights on expanding into U.S. market CoinShares ranks among the top four managers globally by crypto ETP AuM alongside BlackRock, Fidelity, and Grayscale and holds the #1 market position in Europe with 34% market share CoinShares is experiencing a period of significant growth; AuM has more than tripled over the last two years through strong investor inflows, supportive digital asset pricing and successful new p ...

Data to be presented in the Immunotherapy & Cell Therapy in Sarcoma: Emerging Frontiers session at the Connective Tissue Oncology Society (CTOS) 2025 Annual Meeting SYDNEY, AUSTRALIA, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a late-stage immunotherapy company targeting cancer and autoimmune diseases, today announces an abstract for the EFTISARC-NEO Phase II investigator-initiated trial has been accepted for oral presentation at the Connectiv ...

On 5 May 2025, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 20 of 2 May 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 120 million during the period 5 May to 31 December 2025. The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules). Tr ...

Seasoned industry leader to strengthen company’s strategic engagement and policy voice in Medicare AdvantageORANGE, Calif., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) today announced that Matt Eyles will join as executive vice president of government and business strategy, effective Sept. 29. In this newly created position, Eyles will report directly to Alignment founder and CEO John Kao, elevating Alignment’s engagement and leadership in health care policy at federal and s ...

Company remains in good standing on Nasdaq Capital Market; strengthens platform to execute commercialization and growth strategyRENO, Nev., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Aqua Metals, Inc. (NASDAQ: AQMS), a leader in sustainable lithium battery recycling, today announced that it has received written notification from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company has regained compliance with Nasdaq’s minimum bid price requirement for continued listing on the Nasdaq Capital Market and that the m ...

BOSTON, Sept. 08, 2025 (GLOBE NEWSWIRE) -- NeuroNOS, a biopharmaceutical company focused on developing treatments for neurological disorders and neuro-oncology, and a subsidiary of Beyond Air (NASDAQ: XAIR), today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its lead investigational therapy, BA-101, for the treatment of Glioblastoma (GBM). GBM is an aggressive primary brain tumor with limited treatment options and poor prognosis under current standa ...

SINGAPORE, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Rectitude Holdings Ltd. (Nasdaq: RECT; the “Company” or “Rectitude”), a Singapore-based provider of safety equipment and related industrial products, today announced that it is initiating a Bitcoin treasury strategy via entering into a Standby Equity Purchase Agreement (the “SEPA”) with Constantinople Limited, a British Virgin Islands Company led by Tian Jia, an experienced Bitcoin investor, as Lead Investor, and Chen Zhiqiang, former co-founder and CTO of Tron, ...

The Hong Kong–based company introduces a multilingual AI-powered communication tool designed for e-commerce sellers, financial professionals, and global enterprises.Hong Kong, China, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Mohist AI Limited, a Hong Kong–registered technology company, today announced the official launch of TranGPT, a multilingual AI-powered translation and text-to-speech (TTS) Software-as-a-Service (SaaS) platform. Built for cross-border e-commerce, international finance, and global business, Tra ...